Yes-associated protein homolog, YAP-1, is involved in the thermotolerance and aging in the nematode Caenorhabditis elegans

Experimental Cell Research

Volumn 319, Issue 7, 2013, Pages 931-945

  Iwasa, Hiroaki ^a   Maimaiti, Sainawaer ^a,c   Kuroyanagi, Hidehito ^b   Kawano, Shodai ^a   Inami, Kazutoshi ^a   Timalsina, Shikshya ^a   Ikeda, Mitsunobu ^a   Nakagawa, Kentaro ^a   Hata, Yutaka ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c Department of Psychotherapy   (China)

Author keywords

Caenorhabditis elegans; Hippo pathway; TAZ WWTR1; YAP

Indexed keywords

HEAT SHOCK PROTEIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN HOMOLOG;

AGING; ARTICLE; CAENORHABDITIS ELEGANS; GENE SEQUENCE; HEAT TOLERANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TARGETING; SEQUENCE ANALYSIS;

CAENORHABDITIS ELEGANS; MAMMALIA; METAZOA;

EID: 84874963243     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.01.020     Document Type: Article

References (56)

1. Zhao B., Tumaneng K., Guan K.L. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat. Cell Biol. 2011, 13:877-883.
2. Bao Y., Hata Y., Ikeda M., Withanage K. Mammalian Hippo pathway: from development to cancer and beyond. J. Biochem. 2011, 149:361-379.
3. Pan D. The Hippo signaling pathway in development and cancer. Dev. Cell 2010, 19:491-505.
4. Chan S.W., Lim C.J., Chen L., Chong Y.F., Huang C., Song H., Hong W. The Hippo pathway in biological control and cancer development. J. Cell Physiol. 2011, 226:928-939.
5. Oh H., Irvine K.D. Yorkie: the final destination of Hippo signaling. Trends Cell Biol. 2010, 20:410-417.
6. Wang K., Degerny C., Xu M., Yang X.J. YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochem. Cell Biol. 2009, 87:77-91.
7. Hilman D., Gat U. The evolutionary history of YAP and the Hippo/YAP pathway. Mol. Biol. Evol. 2011, 28:2403-2417.
8. Lehtinen M.K., Yuan Z., Boag P.R., Yang Y., Villén J., Becker E.B., DiBacco S., de la Iglesia N., Gygi S., Blackwell T.K., Bonni A. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 2006, 125:987-1001.
9. Kang J., Shin D., Yu J.R., Lee J. Lats kinase is involved in the intestinal apical membrane integrity in the nematode Caenorhabditis elegans. Development 2009, 136:2705-2715.
10. Cai Q., Wang W., Gao Y., Yang Y., Zhu Z., Fan Q. Ce-wts-1 plays important roles in Caenorhabditis elegans development. FEBS Lett. 2009, 583:3158-3164.
11. Curran S.P., Ruvkin G. Lifespan regulation by evolutionary conserved genes essential for viability. PLoS Genet. 2007, 3:e56.
12. Wu J., Duggan A., Chalfie M. Inhibition of touch cell fate by egl-44 and egl-46 in C. elegans. Genes Dev. 2001, 15:789-802.
13. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974, 77:71-94.
14. Kuroyanagi H., Ohno G., Sakane H., Maruoka H., Hagiwara M. Visualization and genetic analysis of alternative splicing regulation in vivo using fluorescence reporters in transgenic Caenorhabditis elegans. Nat. Protoc. 2010, 5:1495-1517.
15. Sutphin G.L., Kaeberlein M. Dietary restriction by bacterial deprivation increases life span in wild-derived nematodes. Exp. Gerontol. 2008, 43:130-135.
16. Iwasa H., Yu S., Xue J., Driscoll M., Novel EGF pathway regulators modulate C. elegans healthspan and lifespan via EGF receptor, PLC-g, and IP3R activation. Aging Cell 2010, 9:490-505.
17. Timmons L., Court D.L., Fire A. Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. Gene 2001, 263:103-112.
18. Kamath R.S., Ahringer J. Genome-wide RNAi screening in Caenorhabditis elegans. Methods 2003, 30:313-321.
19. Iwasa H., Kuroyanagi H., Maimaiti S., Ikeda M., Nakagawa K., Hata Y. Characterization of RSF-1, the Caenorhabditis elegans homolog of the Ras-association domain family protein 1. Exp. Cell Res. 2013, 319:1-11.
20. Bao Y., Nakagawa K., Yang Z., Ikeda M., Withanage K., Ishigami-Yuasa M., Okuno Y., Hata S., Nishina H., Hata Y. A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription. J. Biochem. 2011, 150:199-208.
21. Ota M., Sasaki H. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 2008, 135:4059-4069.
22. Ikeda M., Kawata A., Nishikawa M., Tateishi Y., Yamaguchi M., Nakagawa K., Hirabayashi S, Bao Y., Hidaka S., Hirata Y., Hata Y. Hippo pathway-dependent and -independent roles of RASSF6. Sci. Signal 2009, 2:ra59.
23. Hong J.H., Yaffe M.B. TAZ: a Β-catenin-like molecule that regulates mesenchymal stem cell differentiation. Cell Cycle 2006, 5:176-179.
24. Zhao B., Ye X., Yu J., Li L., Li W., Li S., Lin J.D., Wang C.Y., Chinnaiyan A.M., Lai Z.C., Guan K.L. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008, 22:1962-1971.
25. Nishioka N., Inoue K., Adachi K., Kiyonari H., Ota M., Ralston A., Yabuta N., Hirahara S., Stephenson R.O., Ogonuki N., Makita R., Kurihara H., Morin-Kensicki E.M., Nojima H., Rossant J., Nakao K., Niwa H., Sasaki H. The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev. Cell 2009, 16:398-410.
26. Dong J., Feldmann G., Huang J., Wu S., Zhang N., Comerford S.A., Gayyed M.F., Anders R.A., Maitra A., Pan D. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130:1120-1133.
27. Basu S., Totty N.F., Irwin M.S., Sudol M., Downward J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell 2003, 11:11-23.
28. Zhao B., Li L., Lu Q., Wang L.H., Liu C.Y., Lei Q., Guan K.L. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 2011, 25:51-63.
29. Chan S.W., Lim C.J., Chong Y.F., Pobbati A.V., Huang C., Hong W. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J. Biol. Chem. 2011, 286:7018-7026.
30. Schlegelmilch K., Mohseni M., Kirak O., Pruszak J., Rodriguez J.R., Zhou D., Kreger B.T., Vasioukhin V., Avruch J., Brummelkamp T.R., Camargo F.D. Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell 2011, 144:782-795.
31. Silvis M.R., Kreger B.T., Lien W.H., Klezovitch O., Rudakova G.M., Camargo F.D., Lantz D.M., Seykora J.T., Vasioukhin V. α-Catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci. Signal 2011, 4:ra33.
32. Wada K., Itoga K., Okano T., Yonemura S., Sasaki H. Hippo pathway regulation by cell morphology and stress fibers. Development 2011, 138:3907-3914.
33. Sansores-Garcia L., Bossuyt W., Wada K., Yonemura S., Tao C., Sasaki H., Halder G. Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J. 2011, 30:2325-2335.
34. Hubberstey A.V., Mottilo E.P. Cyclase-associated proteins: CAPacity for linking signal transduction and actin polymerization. FASEB J. 2002, 16:487-499.
35. Cooper J.A., Schafer D.A. Control of actin assembly and disassembly at filament ends. Curr. Opin. Cell Biol. 2000, 12:97-103.
36. Ferrigno O., Lallemand F., Verrecchia F., L'Hoste S., Camonis J., Atfi A., Mauviel A. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-Β/Smad signaling. Oncogene 2002, 21:4879-4884.
37. Alarcón C., Zaromytidou A.I., Xi Q., Gao S., Yu J., Fujisawa S., Barlas A., Miller A.N., Manova-Todorova K., Macias M.J., Sapkota G., Pan D., Massagué J. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-Β pathways. Cell 2009, 139:757-769.
38. Zaidi S.K., Sullivan A.J., Medina R., Ito Y., van Wijnen A.J., Stein J.L., Lian J.B., Stein G.S. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J. 2004, 23:790-799.
39. Zhao B., Wei X., Li W., Udan R.S., Yang Q., Kim J., Xie J., Ikenoue T., Yu J., Li L., Zheng P., Ye K., Chinnaiyan A., Halder G., Lai Z.C., Guan K.L. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007, 21:2747-2761.
40. Hao Y., Chun A., Cheung K., Rashidi B., Yang X. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J. Biol. Chem. 2008, 283:5496-5509.
41. Bertini E., Oka T., Sudol M., Strano S., Blandino G. YAP: At the crossroad between transformation and tumor suppression. Cell Cycle 2010, 8:49-57.
42. Singh V., Aballay A. Regulation of DAF-16-mediated innate immunity in Caenorhabditis elegans. J. Biol. Chem. 2009, 284:35580-35587.
43. Hsu A.L., Murphy C.T., Kenyon C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 2003, 300:1142-1145.
44. Chow D.K., Glenn C.F., Johnston J.L., Goldberg I.G., Wolkow C.A. Sarcopenia in the Caenorhabditis elegans pharynx correlates with muscle contraction rate over lifespan. Exp. Gerontol. 2006, 41:252-260.
45. Glenn C.F., Chow D.K., David L., Cooke C.A., Gami M.S., Iser W.B., Hanselman K.B., Goldberg I.G., Wolkow C.A. Behavioral deficits during early stages of aging in Caenorhabditis elegans result from locomotory deficits possibly linked to muscle frailty. J. Gerontol. A Biol. Sci. Med. Sci. 2004, 59:1251-1260.
46. Herndon L.A., Schmeissner P.J., Dudaronek J.M., Brown P.A., Listner K.M., Sakano Y., Paupard M.C., Hall D.H., Driscoll M. Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature 2002, 419:808-814.
47. Huang C., Xiong C., Kornfeld K. Measurements of age-related changes of physiological processes that predict lifespan of Caenorhabditis elegans. Proc. Nat. Acad. Sci. U.S.A. 2004, 101:8084-8089.
48. Xin M., Kim Y., Sutherland L.B., Qi X., McAnally J., Schwartz R.J., Richardson J.A., Bassel-Duby R., Olson E.N. Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci. Signal 2011, 4:ra70.
49. Zhang J., Ji J.Y., Yu M., Overholtzer M., Smolen G.A., Wang R., Brugge J.S., Dyson N.J., Haber D.A. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat. Cell Biol. 2009, 11:1444-1450.
50. Kenyon C., Chang J., Gensch E., Rudner A., Tabtiang R. A, C. elegans mutant that lives twice as long as wild type. Nature 1993, 366:461-464.
51. Li Z., Zhao B., Wang P., Chen F., Dong Z., Yang H., Guan K.L, Xu Y. Structural insights into YAP and TEAD complex. Genes Dev. 2009, 24:235-240.
52. Β-TRCP. Genes Dev. 2010, 24:72-85.
53. Huntoon C.J., Nye M.D., Geng L., Peterson K.L., Flatten K.S., Haluska P., Kaufmann S.H., Karnitz L.M. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway. Cancer Res. 2010, 70:8642-8650.
54. Morin-Kensicki E.M., Boone B.N., Howell M., Stonebraker J.R., Teed J., Alb J.G., Magnuson T.R., O'Neal W., Milgram S.L. Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65. Mol. Cell. Biol. 2006, 26:77-87.
55. Williams G.C. Pleiotropy, natural selection, and the evolution of senescence. Evolution 1957, 11:398-411.
56. Ungewitter E. H. Scrabble, Antagonistic pleiotropy and p53. Mech. Ageing Dev. 2009, 130:10-17.